PSGL-1

PSGL-1

PSGL-1 詳細

Molecule Name
P-selectin glycoprotein ligand-1
分子の別称
PSGL1,CD162,SELPLG,Selectin P ligand
Drug Development Progress
治験薬の数4
市販薬剤の数0
研究&開発段階Phase 2 Clinical
ターゲットの別称
P-selectin glycoprotein ligand 1,PSGL-1,SELPLG,Selectin P Ligand,Cutaneous Lymphocyte-Associated Associated Antigen,CD162 Antigen,CD162,PSGL1,CLA
バックグランド
P-selectin glycoprotein ligand 1 (PSGL-1) is also known as Selectin P ligand (SELPLG), CD antigen CD162. PSGL-1 is disulfide-linked homodimer which is the high affinitycounter-receptor for P-selectin on expressed on activated endothelial cells and platelets. PSGL-1 / SELPLG interacts with P-, E- and L-selectins, through their lectin/EGF domains, is required for promoting recruitment and rolling of leukocytes. These interactions require sialyl Lewis X glycan modification but there is a differing dependence for tyrosine sulfations. Dimerization appears not to be required for P-selectin/SELP binding. PSGL-1 can interact with SNX20, MSN and SYK. PSGL-1 / SELPLG mediate the activation of SYK by SELPLG.

PSGL-1 製品リスト

No Data
You Have Viewed 0 Of 0 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

治験薬に関する情報

英語名研究コード研究開発ステージ会社適応症臨床試験
CepeprubartSelK-2Phase 2 ClinicalSelexys
Asthma; Pulmonary Disease, Chronic Obstructive; Venous Thromboembolism
詳細
LeiolizumabAbGn 168H2; AbGn-268; AbGn-168H2; ALTB-268Phase 2 ClinicalAltrubio Inc
Arthritis, Psoriatic; Colitis, Ulcerative
詳細
NeihulizumabAbGn-168; AbGn-168H; ALTB-168Phase 1 ClinicalAltrubio Inc
Arthritis, Psoriatic; Colitis, Ulcerative; Graft vs Host Disease; Plaque psoriasis; Psoriasis
詳細
SSGJ-617SSGJ-617; SSGJ617; 61X; VTX-0811; 617Phase 1 ClinicalVerseau Therapeutics Inc
Solid tumours
詳細